(NASDAQ:GLSI), STAFFORD, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the completion of enrollment in the open label non-HLA-A*02 arm of FLAMINGO-01. In the […]

(TSX:MUX),(NYSE:MUX), TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) is advancing three key areas at its Gold Bar Mine Complex in the Eureka Mining District of Nevada, to increase resources, extend mine life and potentially increase annual gold production: 1) Lookout Mountain 2) Windfall, and now 3) Unity

(NASDAQ:EHGO), New York, Dec. 08, 2025 (GLOBE NEWSWIRE) — Shanghai, December 8, 2025 — Eshallgo Inc. (“Eshallgo” or the “Company”) (Nasdaq: EHGO), a provider of integrated office and enterprise technology along with a suite of AI intelligence solutions in China, today announced a series of business developments achieved in 2025 and growth outlook heading into

(NYSE:GNL), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”) announced today that it has entered into an agreement (the “Agreement”) to sell the McLaren Campus (comprising the McLaren Technology Centre, Production Centre and Thought Leadership Centre) – a three-building, 840,000-square-foot property located in Woking, Surrey,

(NasdaqGM:MNOV),(TSE:4875.T),(TSE:4875), LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code: 4875), today announced an update and the patients' basic characteristics data from its Phase 2b/3 clinical trial of MN-166 (ibudilast) in Amyotrophic

(NasdaqGM:SNWV), Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased

WEBUY GLOBAL LTD. Partners with WITSTAR Group to Expand into Cross-Border Education Market Collaboration Opens New Growth Channel Connecting Malaysia-China Education and Cultural Exchange GlobeNewswire December 08, 2025 Singapore, Dec. 08, 2025 (GLOBE NEWSWIRE) — WEBUY GLOBAL LTD. (Nasdaq: WBUY), a fast-growing Southeast Asian e-commerce and lifestyle technology company, announced that its subsidiary, Webuy Advisory

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 GlobeNewswire December 08, 2025 STAFFORD, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences,

Successful Exploration Transforming McEwen's Gold Bar Mine Complex Sets the Stage for Meaningful Mine Life Extension GlobeNewswire December 08, 2025 TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) is advancing three key areas at its Gold Bar Mine Complex in the Eureka Mining District of Nevada, to increase

MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND GlobeNewswire December 08, 2025 LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV)